[Hematologic intensive care units for cancer patients. Their role in the efficacy of cytostatic chemotherapy].
Intensive care units for hematology or oncology patients consist of rooms free from pathogenic germs and low in microbe content. The units are staffed by doctors and nurses checked to be non carriers of pathogenic germs, and platelet and granulocyte transfusions are available. The first of these rooms, the Unit Fred-Siguier at the Hospital Paul-Brousse (Villejuif), was created for patients receiving bone marrow transplantation. Several units now exist in Europe. Results from two cooperative chemotherapy trials conducted at a European level showed that the number of remissions was double in services equipped with such rooms when compared with other hospital services. The study thus provides further evidence of the great need for such intensive care units.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D003428:Cross Infection / Q000517:prevention & control; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D017053:Infection Control; D007362:Intensive Care Units; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D010357:Patient Isolators; D013866:Thioguanine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin
Unités de soins intensifs hématocancérologiques. Leur rôle dans l'efficacité des chimiothérapies cytostatiques